Lung Cancer Dispatch
4.7K views | +0 today
Follow
Lung Cancer Dispatch
News for Patients and Physicians
Curated by Cancer Commons
Your new post is loading...
Your new post is loading...
Scooped by Cancer Commons
Scoop.it!

More than 130 Lawmakers Urge Coverage for Lung Cancer Test that Could Cost Medicare Billions

More than 130 Lawmakers Urge Coverage for Lung Cancer Test that Could Cost Medicare Billions | Lung Cancer Dispatch | Scoop.it

"More than 130 lawmakers are urging the Obama administration to expand coverage for a lung-cancer test under Medicare that could cost the program billons, calling the screening important for vulnerable seniors.

"In a letter to the Centers for Medicare and Medicaid Services, the lawmakers called for a timely decision on coverage for low-dose CT scans for older patients at higher risk of developing lung cancer."

Cancer Commons's insight:

StarTribune  |  Jun 17, 2014

more...
No comment yet.
Scooped by Cancer Commons
Scoop.it!

CMS Advisory Panel Rejects Medicare Coverage for Lung Cancer Screening

CMS Advisory Panel Rejects Medicare Coverage for Lung Cancer Screening | Lung Cancer Dispatch | Scoop.it

"A CMS panel today rejected the concept of national Medicare coverage of annual lung cancer screening for high-risk individuals.


"The Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) conducted a daylong hearing during which several clinicians and members of the public testified about the benefits and risks of lung cancer screening with low-dose CT."

Cancer Commons's insight:

Healio  |  Apr 30, 2014

more...
No comment yet.
Scooped by Cancer Commons
Scoop.it!

Lung Cancer Screening Would Cost Medicare Billions

Lung Cancer Screening Would Cost Medicare Billions | Lung Cancer Dispatch | Scoop.it

"Implementation of a national lung cancer screening program using low-dose computed tomography (LDCT) will identify almost 55,000 additional lung cancer cases over 5 years, but will add more than $9 billion to Medicare expenditures, according to results of a new study.


"Joshua A. Roth, PhD, of the Fred Hutchinson Cancer Research Center in Seattle, discussed the economic analysis during a press conference in advance of the American Society of Clinical Oncology (ASCO) Annual Meeting, where results will be formally presented at the end of the month. He noted that following the positive results of the National Lung Screening Trial, the US Preventive Services Task Force recently recommended LDCT screening in healthy persons between the ages of 55 and 80 with at least 30 pack-years of smoking history. Medicare, meanwhile, is expected to release a draft decision on screening coverage in November of this year. 'That decision will likely heavily weight the Task Force’s recommendation,' Roth said."

Cancer Commons's insight:

Cancer Network  |  May 15, 2014

more...
No comment yet.
Suggested by Cancer Commons
Scoop.it!

Colorado Medicare Will Cover VeriStrat Test for Guiding Lung Cancer Treatment

Colorado’s Medicare provider has announced that it will cover VeriStrat, a test designed to guide decisions about second-line therapies for advanced non-small cell lung cancer (NSCLC). The main second-line therapy options in NSCLC include chemotherapy or the drug erlotinib (Tarceva). While Tarceva can significantly improve outcomes in patients with mutations in the EGFR gene, it also benefits some patients without these mutations. VeriStrat, a rapid blood test, helps predict which of these patients would be more likely to respond to Tarceva and which would be better served by other treatments. Medicare coverage will allow many more patients in Colorado to access this useful tool.

Cancer Commons's insight:

Fort Mill Times | June 20, 2013

more...
No comment yet.